News & Analysis as of

Opioid Regulatory Reform Cannabis Products

Benesch

Cannabis Industry Quarterly Update: Q2 2025

Benesch on

The Trump administration’s 2025 drug policy agenda omits cannabis rescheduling, despite earlier signals of support, instead prioritizing fentanyl, border security, and addiction treatment. This omission, coupled with a...more

Nelson Mullins Riley & Scarborough LLP

Gold Dome Report - Legislative Day 32 - March 2024

Friday marked the end of what felt like the longest week in legislative history — and the beginning of a three-week sprint to Legislative Day 40. While most lawmakers and lobbyists are eager for adjournment sine die, it...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide